Interruption of nuclear localization of ATBF1 during the histopathologic progression of head and neck squamous cell carcinoma
Xiaodong Sun(Hubei University of Medicine), Jin‐Tang Dong(Southern University of Science and Technology), Gabriel Sica(Emory University), Xiaoying Fu(Southern University of Science and Technology), Zhengjia Chen(Hunan University of Traditional Chinese Medicine), Xue–Yuan Dong(Emory University), Jie Li(Qingdao University), Peng Guo(Ministry of Education of the People's Republic of China), Zhuo Chen(First Affiliated Hospital of Zhengzhou University), Yuxiang Wang(Emory University), Susan Müller(Emory University), Songqing Fan(Central South University), Dong M. Shin(Emory University)
Cited by 11
Related Papers
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
B7-H3: A costimulatory molecule for T cell activation and IFN-γ production
|Nature Immunology|2001|1k
Recent Advances in Head and Neck Cancer
|New England Journal of Medicine|2008|926
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
|Proceedings of the National Academy of Sciences|2017|899